Is Long-Term Anticoagulation Required after Stent Placement for Benign Superior Vena Cava Syndrome?

Haddad, Mustafa M.; Thompson, Scott M.; McPhail, Ian R.; Bendel, Emily C.; Kalra, Manju; Stockland, Andrew H.; Neidert, Newton B.; Andrews, James C.; Misra, Sanjay; Bjarnason, Haraldur; Neisen, Melissa

doi:10.1016/j.jvir.2018.07.020

Cited by 23 publications

(21 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Whether prolonged oral anticoagulation will prevent recurrent occlusion is not entirely clear; however, a recent study by Haddad and colleagues 11 does not suggest a clinical benefit of prolonged oral anticoagulation after endovascular treatment.…”

Section: Discussionmentioning

confidence: 99%

Benign vena cava superior syndrome in patients with cardiac implantable electronic devices: Presentation and management

Eberhardt

Bunck

Codjambopoulo³

et al. 2020

HeartRhythm Case Reports

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Benign vena cava superior syndrome in patients with cardiac implantable electronic devices: Presentation and management

Eberhardt

Bunck

Codjambopoulo³

et al. 2020

HeartRhythm Case Reports

View full text Add to dashboard Cite

“…Sheikh et al used anticoagulation in 10 of 19 patients with a chronic indwelling device, or in the setting of stent malposition 6 . Further study reported that no significant difference was observed in clinical and treatment outcomes in patients who did and did not receive anticoagulation after stent placement for benign SVCS 7 . Therefore, the risks and benefits of anticoagulation must be individualized for the patient.…”

Section: Discussionmentioning

confidence: 99%

“…Although endovascular techniques have now become the major option with encouraging outcomes, [5][6][7][8][9] there is currently a lack of high-level studies on the endovascular treatment for tCVC-induced SVCS. 1 In this study, we retrospectively report single institution's experience on the efficacy and safety of stent placement in HD patients with tCVC-induced SVC occlusion (SVCO).…”

Section: Introductionmentioning

confidence: 99%

Endovascular treatments of tunneled central venous catheter‐induced superior vena cava complete occlusion via through‐and‐through technique

Zeng

Chen

et al. 2020

Hemodialysis International

View full text Add to dashboard Cite

Background Superior vena cava occlusion (SVCO) induced by tunneled central venous catheter (tCVC) is an uncommon but challenging complication of hemodialysis patients. The aim of this study was to access the efficacy, safety, and patency of stents in tCVC‐related SVCO via through‐and‐through technique. Method We retrospectively identified seven patients with benign SVCO secondary to tCVC treated with endovascular approaches successfully between 1 March 2013 and 31 October 2019. Patients' demographic data, clinical signs and symptoms, and imaging data were followed up and recorded. Results Technical success was achieved in all cases. All the patients were performed with percutaneous transcatheter angioplasty (PTA) and subsequently stent placement via the through‐and‐through technique. During follow‐up, four patients underwent secondary interventions, including PTA and/or stent placement. The primary patency after 3, 6, 9 and 12 months was 100%, 100%, 86% and 86%, and secondary patency after 12 months was 100%. No procedure‐related deaths occurred. Conclusions Endovascular management of SVCO is a safe and effective approach. CT examination can provide a direction for endovascular treatment and periodic surveillance.

show abstract

“…Following delivery of the stent, angioplasty is performed to ensure the stent is adequately dilated and the stent wall abuts the vessel wall. Final diameter of the stent is determined based on the prior venograms and IVUS measurements (Haddad et al 2018). Post stent venogram should show decreased number of adjacent collaterals, in-line flow of the deep venous structures, and no filling defects within the stent complex.…”

Section: Recanalization Of Chronic Venous Occlusionsmentioning

confidence: 99%

“…Covered stenting is necessary when the vessel wall or adjacent pericardium has been torn from either angioplasty or stenting of the SVC, and the pericardial space fills with blood which may lead to cardiac tamponade. In some instances, a pericardial drain may also be required to decrease the pressure on the heart (Haddad et al 2018).…”

Section: Complications From Venous Recanalizationmentioning

confidence: 99%

Managing systemic venous occlusions in children

Gill

Shivaram

2020

CVIR Endovasc

View full text Add to dashboard Cite

Pediatric venous disease is increasing in incidence in both inpatient and outpatient populations. The widespread use of central venous access devices as well as the rising incidence of thromboembolic events in pediatrics is leading to more systemic venous occlusions in both the central and peripheral veins. This review focuses on the etiology, presentation, workup, and general technical considerations of recanalization as well as procedural complications related to pediatric systemic venous occlusive disease. The potential role for pediatric interventional radiology guided treatments will be discussed in detail.

show abstract

Is Long-Term Anticoagulation Required after Stent Placement for Benign Superior Vena Cava Syndrome?

Cited by 23 publications

References 29 publications

Benign vena cava superior syndrome in patients with cardiac implantable electronic devices: Presentation and management

Benign vena cava superior syndrome in patients with cardiac implantable electronic devices: Presentation and management

Endovascular treatments of tunneled central venous catheter‐induced superior vena cava complete occlusion via through‐and‐through technique

Managing systemic venous occlusions in children

Contact Info

Product

Resources

About